Blog - Vidan Diagnostics

Next Generation Procalcitonin Assay for Sepsis Management

DiaSys Diagnostics Receives FDA 510(k) Clearance for Procalcitonin FS [...]

By tx360|2025-07-09T21:17:04-05:00June 5, 2025|Press Release|Comments Off

Vidan Diagnostics to attend the Medica 2025 Trade Fair [...]

By tx360|2025-05-29T08:43:12-05:00May 16, 2025|News|Comments Off

Vidan Diagnostics to attend the ADLM 2025 Annual Scientific [...]

By tx360|2025-05-29T14:24:14-05:00May 16, 2025|News|Comments Off

Next Generation Beta-hydroxybutyrate Reagent For Beckman Coulter DxC 500 [...]

By tx360|2025-05-29T14:24:19-05:00May 16, 2025|Press Release|Comments Off

Vidan Diagnostics to attend the 2023 AACC Annual Scientific [...]

By tx360|2024-10-04T11:50:18-05:00January 6, 2023|Events, News, Press Release|Comments Off

Vidan Diagnostics Beta-hydroxybutyrate Assay Prefered by Hospital Laboratories Proficiency [...]

By tx360|2024-10-04T11:46:36-05:00November 29, 2022|News, Press Release|Comments Off

Vidan Diagnostics Key Focus Remains on Implementing Its Strategy [...]

By tx360|2024-10-04T11:46:42-05:00April 20, 2022|News, Press Release|Comments Off

Vidan Diagnostics to attend the 2022 AACC Annual Scientific [...]

By tx360|2023-01-11T16:24:23-06:00March 23, 2022|Events, News, Press Release|Comments Off

Vidan Diagnostics Introduces Patient Samples to Validate Beta-Hydroxbutyrate Assay [...]

By tx360|2022-11-23T17:20:16-06:00October 27, 2021|News, Press Release|Comments Off

Vidan Diagnostics Launches Next Generation βeta-Hydroxybutyrate Assay on Roche [...]

By tx360|2022-11-23T17:20:33-06:00August 14, 2021|News, Press Release|Comments Off